Could a single drug let HIV patients ditch daily meds?
NCT ID NCT07145164
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 23 times
Summary
This study tests whether a drug called N-803 (IL-15) can boost the immune system to control HIV without daily antiretroviral therapy. 20 adults with well-controlled HIV will receive the drug or placebo, then temporarily stop their regular HIV meds to see if the virus stays suppressed. The goal is to find a way to reduce or eliminate the need for lifelong daily pills.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UCSF
San Francisco, California, 94044, United States
Conditions
Explore the condition pages connected to this study.